Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
13,210,000
|
16,075,000
|
16,445,000
|
17,374,000
| Cost of Revenue | 9,828,000 | 12,097,000 | 11,836,000 | 12,478,000 | |
Gross Profit
|
3,382,000
|
3,978,000
|
4,609,000
|
4,896,000
| |
|
Operating Expenses |
|
Research Development | 562,000 | 613,000 | 634,000 | 632,000 |
|
Selling General and Administrative | 1,602,000 | 1,747,000 | 1,379,000 | 1,648,000 |
|
Non Recurring |
-
| 580,000 |
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,218,000
|
1,038,000
|
2,596,000
|
2,616,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 29,000 | (11,000) | (17,000) | 70,000 |
|
Earnings Before Interest And Taxes | 1,247,000 | 1,027,000 | 2,579,000 | 2,686,000 |
|
Interest Expense | 120,000 | 115,000 | 129,000 | 110,000 |
|
Income Before Tax | 1,127,000 | 912,000 | 2,450,000 | 2,576,000 |
|
Income Tax Expense | 246,000 | 214,000 | 753,000 | 872,000 |
|
Minority Interest | (2,000) | (3,000) | (3,000) | (10,000) |
|
|
|
Net Income From Continuing Ops | 880,000 | 697,000 | 1,699,000 | 1,699,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
880,000
|
697,000
|
1,699,000
|
1,699,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
880,000
|
697,000
|
1,699,000
|
1,699,000
|
|